Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ronald Geyer

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Leukemia Research|July 27, 2005
5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylationStuart A Scott, Wei-Feng Dong, Ryo Ichinohasama, et al.
Nucleic Acids Research|March 12, 2019
Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputsKris Barreto, Bharathikumar V Maruthachalam, Wayne Hill, et al.
BMC Genomics|May 7, 2015
Quantitative and multiplexed DNA methylation analysis using long-read single-molecule real-time bisulfite sequencing (SMRT-BS)Yao Yang, Robert Sebra, Benjamin S Pullman, et al.
Journal of Hematology & Oncology|July 16, 2009
RIZ1 is potential CML tumor suppressor that is down-regulated during disease progressionAshakumary Lakshmikuttyamma, Naoto Takahashi, Elodie Pastural, et al.
Scientific Reports|April 23, 2017
Enhancing the throughput and multiplexing capabilities of next generation sequencing for efficient implementation of pooled shRNA and CRISPR screensMd Fahmid Islam, Atsushi Watanabe, Lai Wong, et al.
Chembiochem : a European Journal of Chemical Biology|September 9, 2017
A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining RegionsBharathikumar Vellalore Maruthachalam, Ayman El-Sayed, Jianghai Liu, et al.
Cancers|November 25, 2020
Nimotuzumab Site-Specifically Labeled with <sup>89</sup>Zr and <sup>225</sup>Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive CancersViswas Raja Solomon, Kris Barreto, Wendy Bernhard, et al.
Cancers|February 4, 2021
<sup>89</sup>Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In VivoElahe Alizadeh, Khan Behlol Ayaz Ahmed, Viswas Raja Solomon, et al.
ACS Pharmacology & Translational Science|July 17, 2025
Olfactory Drug Delivery in Rodents: Deposition and PharmacokineticsThomas M Morin, Nick Allan, Jacob M Hooker, et al.
Protein Science : a Publication of the Protein Society|May 25, 2026
Dual targeting of inhibitory EGFR epitopes with synthetic antibodies in therapeutic-resistant cancersJarrett J Adams, Evan Mallette, Max London, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Leukemia Research|July 27, 2005
5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylationStuart A Scott, Wei-Feng Dong, Ryo Ichinohasama, et al.
Nucleic Acids Research|March 12, 2019
Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputsKris Barreto, Bharathikumar V Maruthachalam, Wayne Hill, et al.
BMC Genomics|May 7, 2015
Quantitative and multiplexed DNA methylation analysis using long-read single-molecule real-time bisulfite sequencing (SMRT-BS)Yao Yang, Robert Sebra, Benjamin S Pullman, et al.
Journal of Hematology & Oncology|July 16, 2009
RIZ1 is potential CML tumor suppressor that is down-regulated during disease progressionAshakumary Lakshmikuttyamma, Naoto Takahashi, Elodie Pastural, et al.
Scientific Reports|April 23, 2017
Enhancing the throughput and multiplexing capabilities of next generation sequencing for efficient implementation of pooled shRNA and CRISPR screensMd Fahmid Islam, Atsushi Watanabe, Lai Wong, et al.
Chembiochem : a European Journal of Chemical Biology|September 9, 2017
A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining RegionsBharathikumar Vellalore Maruthachalam, Ayman El-Sayed, Jianghai Liu, et al.
Cancers|November 25, 2020
Nimotuzumab Site-Specifically Labeled with <sup>89</sup>Zr and <sup>225</sup>Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive CancersViswas Raja Solomon, Kris Barreto, Wendy Bernhard, et al.
Cancers|February 4, 2021
<sup>89</sup>Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In VivoElahe Alizadeh, Khan Behlol Ayaz Ahmed, Viswas Raja Solomon, et al.
ACS Pharmacology & Translational Science|July 17, 2025
Olfactory Drug Delivery in Rodents: Deposition and PharmacokineticsThomas M Morin, Nick Allan, Jacob M Hooker, et al.
Protein Science : a Publication of the Protein Society|May 25, 2026
Dual targeting of inhibitory EGFR epitopes with synthetic antibodies in therapeutic-resistant cancersJarrett J Adams, Evan Mallette, Max London, et al.
Pageof 5